The key objective was to establish suitable analytical targets by examining human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to confirm the final results in genuine urine specimens and to determine AB-FUBINACA's metabolic balance in human liver microsomes and compared hepatocyte and urine outcomes with in silico